$3.845
+0.097 (+2.53%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
VNDA Prediction & Forecast by Similar Chart Analysis
Alphio's VNDA stock price prediction model matches the current Vanda Pharmaceuticals Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $3.80 (-1.30%). The 1-week path is $3.70 (-3.81%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Vanda Pharmaceuticals Inc Stock?
Vanda Pharmaceuticals Inc is currently priced at $3.88, which is significantly below its 52-week high of $9.94, indicating potential upside. However, the stock has a low RSI of 35.207, suggesting it is oversold, but the forward P/E ratio is high at 103.09, indicating that the stock may be overvalued based on future earnings expectations. The recent insider selling has increased by 972.59%, which raises concerns about the company's outlook. Therefore, while there is potential for recovery, the risks associated with high valuation and insider selling suggest a hold position for now.
VNDA stock price ended at $3.85 on Wednesday, after rising +2.53%
Vanda Pharmaceuticals Inc (VNDA) last closed at $3.845, gaining +2.53%. These facts feed the 1-day and 1-week VNDA price prediction above.
Analyst Consensus
Vanda Pharmaceuticals Inc (VNDA): 5 buy, 0 hold, 1 sell. Outlook: Strong Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Forecast Drivers
Vanda Pharmaceuticals Inc (VNDA) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches VNDA, ranked by similarity.
Seasonality analysis for VNDA
Historically the probability of a positive November return for VNDA is 62.79%. December offers the highest probability of a positive month at 100.00%, while January is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for VNDA
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Nov 2026 | $4.91 | $6.02 | $7.09 | +56.66% |
| Dec 2026 | $4.78 | $5.69 | $6.72 | +48.00% |
In 2026, Vanda Pharmaceuticals Inc (VNDA) is projected to range from $4.78 to $7.09.
Vanda Pharmaceuticals Inc 2026 monthly forecast
In Nov 2026, Vanda Pharmaceuticals Inc is projected to average $6.02, with a low of $4.91 and high of $7.09.
In Dec 2026, Vanda Pharmaceuticals Inc is projected to average $5.69, with a low of $4.78 and high of $6.72.
Related articles
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.